Navigation Links
Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
Date:6/21/2013

SAN DIEGO and IRVINE, Calif., June 21, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq™) and IG-004 (TOCOSOL® paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine (CLINAM) and the European Technology Platform on Nanomedicine (ETPN) in Basel, Switzerland on June 23 - 26. Sorrento has the right to acquire IGDRASOL pursuant to a previously-announced option agreement, entered into in March 2013.

IGDRASOL'S data mining of the clinical data for both IG-001 and IG-004 has generated exciting insights into the field of nanomedicine, which will be presented at the joint meeting. These findings are highly relevant to the theme of this year's conference, namely "Nanomedicine & Targeted Medicine – the paradigm of precise, highly effective and innocuous medicine for the benefit of patients and mankind".

IG-001 (Cynviloq™) is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries as Genexol-PM®. It has completed Phase 1 or 2 trials in metastatic breast cancer (MBC), non-small cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and bladder cancer in the U.S. and/or ex-U.S. IGDRASOL is preparing for an "End of Phase 2" meeting scheduled with the U.S. Food & Drug Administration (FDA) in July 2013, regarding the clinical development of Cynviloq™. As an injectable nanoparticle formulation of paclitaxel, Cynviloq™ may be eligible for approval through the FDA's 505(b)(2) bioequivalence regulatory pathway versus albumin-bound paclitaxel (nab-paclitaxel; Abraxane®) in its currently approved MBC and NSCLC ind
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
2. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
3. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
6. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
7. Sorrento Therapeutics Awarded Third Phase I STTR Grant
8. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
9. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
10. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
11. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... BOSTON , Aug. 29, 2014   Vittamed Corporation ... Boston announced today that T. (Teo) Forcht ... to the company,s Board of Directors. " ... distinguished career in neurosurgery, medical innovation and venture capital," said ... are extremely delighted to add his clinical, strategic, and entrepreneurial ...
(Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... N.Y., June 13, 2011 Henry Schein, Inc., (NASDAQ: ... and services to office-based practitioners, announced today that ... Schein, and Steven Paladino, the Company,s Executive Vice President and ... Stock Conference.  The conference is taking place at the Four ...
... BOSTON, June 13, 2011 Guidelines that reduce the use ... gentler form of respiratory support can profoundly affect those children,s ... team of researchers at Children,s Hospital Boston. ... of Newborn Medicine at Children,s Hospital Boston and the Neonatal ...
Cached Medicine Technology:Henry Schein to Present at the William Blair 31st Annual Growth Stock Conference 2Guidelines for Ventilator Use Help Premature Infants Breathe Easier 2Guidelines for Ventilator Use Help Premature Infants Breathe Easier 3
(Date:8/29/2014)... August 29, 2014 The 8th Annual Paint ... Dine for a Cause, Pink Pooch Contest, Light of Life ... Me Knots" Pink Bow Campaign – all in support of ... and twist this year…. Paint Columbus Pink Foam and Obstacle ... Cascade Hills, 727 54th Street, Columbus, Georgia 31904. It will ...
(Date:8/29/2014)... by volunteering are getting more out of it than ... health boost! , A new study, led ... and published online this week in Psychological Bulletin ... at all the available peer-reviewed evidence regarding the psychosocial ... Lead investigator Dr. Nicole Anderson, together with scientists from ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... inventor from Harrisburg, Pa., had to have breast reconstruction. ... to be sub-par, so she decided that there needed ... a better look for a woman or man who ... visible, as well as promotes confidence and peace of ...
(Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
(Date:8/29/2014)... Ore. (PRWEB) August 29, 2014 University ... of health sciences professionals, announced that Daniel Redwood, DC, ... was named “Educator of the Year,” by the Missouri ... banquet on August 21. , Patrick Montgomery, DC, president ... appointed member of the Missouri House Task Force for ...
Breaking Medicine News(10 mins):Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2
... one expert says, , MONDAY, April 26 (HealthDay News) ... are much less likely to start drinking alcohol at ... questioned nearly 3,600 middle-school children in New England and ... percent of the kids who said their parents never ...
... set well before menopausebut exercise can help rewrite the ... Declining estrogen levels have long been associated with ... these levels drop, according to Dr. Joseph Cannon, Kellet ... the National Institute of Aging-funded study. It,s during that ...
... established risk factors, study finds, , MONDAY, April 26 ... odds of breast cancer in white women have less impact ... for postmenopausal women in the study, "recent hormone use and ... big a role in Hispanics," said Dr. Lisa M. Hines, ...
... ... the mosquito exterminator – welcomes Steven and Kelly Sanders as their newest franchisees ... Marietta, GA (PRWEB) ... announce Steven and Kelly Sanders as their newest franchisees in the Marietta, GA area. ...
... Dr. ... residents safe and effective cosmetic and aesthetic treatments. Advanced Aesthetics utilizes top of ... ... art of aesthetics is continually changing. As technology progresses, innovative treatments replace their ...
... whose parents restrict access to R-rated movies are substantially less likely ... such films, a new study suggests., In a study of ... kids who said their parents never allowed them to watch R ... Of that group, 3 percent said they ...
Cached Medicine News:Health News:Watching R-Rated Movies May Lead to Early Alcohol Use 2Health News:Exercise can forestall osteoporosis 2Health News:Breast Cancer Risks Not Same for Hispanic Women 2Health News:Breast Cancer Risks Not Same for Hispanic Women 3Health News:Mosquito Squad Opens New Location in Marietta, Georgia 2Health News:Mosquito Squad Opens New Location in Marietta, Georgia 3Health News:In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics 2Health News:In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics 3Health News:Keeping kids away from R-rated movies may prevent early drinking 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: